WebMay 2008-Present Bioniche Therapeutics Limited Sub-Investigator Open-Label, Multi-Center Study of the efficacy and safety of MCC in the treatment of patients with non-muscle invasive (Superficial) bladder cancer at high risk of progression and who are refractory to BCG. PROFESSIONAL AFFILIATIONS: American Urological Association WebJun 2, 2011 · Canada-based biopharmaceutical company Bioniche Life Sciences launched a new livestock manufacturing facility on 29 April 2011. The GMP-compliant facility is …
Bioniche Achieves Two Additional Milestones Under Licensing
WebNov 1, 2001 · 1 Bioniche Therapeutics Research Centre, Montréal, Québec, Canada. PMID: 11746260 DOI: 10.1002/pros.1130 Abstract Background: We have isolated a mycobacterial cell wall-DNA complex (MCC) possessing anti-cancer activity against bladder cancer cells. The anti-cancer activity of MCC appears to be due to two effects: a direct … WebVice President, Clinical Operations at Cognito Therapeutics Toronto, Ontario, Canada. 862 followers 500+ connections. Join to view profile … grain fed meat brands
Pro-apoptotic and immunomodulatory activity of a mycobacterial …
WebJan 31, 2013 · Corporate News Release Bioniche Life Sciences Inc. Terminates its License Agreement with Trophogen Inc. 30/01/13 BELLEVILLE, ON, January... April 11, 2024 WebMar 13, 2009 · Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 200 skilled personnel … WebJun 23, 1999 · BIONICHE THERAPEUTICS INC. BIONICHE THERAPEUTICS INC. (Corporation Number: 3632083) was incorporated on 1999-06-23 in Canada. Their … grain feed